Berylson Capital Partners’s CM Life Sciences II Inc. Unit CMIIU Stock Holding History
Bought
Maintained
Sold
Berylson Capital Partners's CMIIU Position: Q3 2021 in Review
Berylson Capital Partners sold out of CM Life Sciences II Inc. Unit (CMIIU) in Q3 2021, closing a stake of 384,164 shares — an estimated $5.17M sold.
Berylson Capital Partners first reported a position in CMIIU in Q1 2021 and held it in 2 quarters. The position peaked at $5.17M in Q2 2021. 0 funds tracked by Wall St. Rank hold CMIIU as of Q3 2021.
- Berylson Capital Partners reported no remaining CM Life Sciences II Inc. Unit position as of Q3 2021 after selling out during the quarter.
- Berylson Capital Partners sold 384,164 CM Life Sciences II Inc. Unit shares in Q3 2021, an estimated $5.17M.
- Berylson Capital Partners first reported a position in CM Life Sciences II Inc. Unit in Q1 2021 and held it in 2 quarters.
- Berylson Capital Partners's CM Life Sciences II Inc. Unit position peaked at $5.17M in Q2 2021.
- 0 funds tracked by Wall St. Rank held CM Life Sciences II Inc. Unit as of Q3 2021.
Based on Berylson Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.